1.The analysis of cholescintigraphy in differentiating the causes of jaundice
Jung Gyun KIM ; So Yeob SOON ; Kwang Su BAE ; Moo Chan CHUNG ; Deuk Lin CHOI ; Ki Jung KIM
Journal of the Korean Radiological Society 1985;21(4):639-649
As a adjuvant, 99m Tc-IDA complex cholescintigraphy has been used to differentiate the causes of jaundice,hepatocellular jaundice from the obstructive jaundice. So we conducted the retrospective study from the 41 casesof cholescintigraphy from the Mar, 83 to Sept. 84 at the Dept. of radiology in the Sonnchyunhyang university todetermine the etiology and differential points in the diagnosing the Jaundice. The following results wereobtainend; 1. As a 1st-ordered parameter, the leading edge hepatic parenchymal transit time was very significant in differentiating the causes of jaundice, among the hepatocellular jaundice, obstructive jaundice due to tumor,and obstructive jaundice due to cholelithiasis. (P<0.01 by X2-test) 2. As a 2nd-ordered parameter, hepaticclearance was very significant in differentiating the hepatocellular jaundice from the jaundice due to partialbiliary obstruction. (P>0.01 by t-test) 3. The difference in hepatic clearance between the biliary obstruction dueto tumor and that of the cholelithiasis, was not significant. (P>0.05 by X2-test) 4. The difference in bile ductdilatation among the hepatocellular jaundice obstructive jaundice due to tumor, and obstructive jaundice due tocholelithiasis, was singnificant in differentiating the causes of jaundice. (P<0.05 by X2-test) 5. Intrahepaticstone showed scintigraphic pooling with partial stasis. 6. Cholescintigraphy was useful to differentiated the Rotor's syndrome from the Dubin-Johnson syndrome, supplying the additional criteria.
Bile
;
Cholelithiasis
;
Jaundice
;
Jaundice, Chronic Idiopathic
;
Jaundice, Obstructive
;
Retrospective Studies
2.Clinical features of acute viral hepatitis B in Korea: a multi-center study.
Hye Jin CHOI ; Soon Young KO ; Won Hyeok CHOE ; Yeon Seok SEO ; Ji Hoon KIM ; Kwan Soo BYUN ; Young Seok KIM ; Seung Up KIM ; Soon Koo BAIK ; Jae Youn CHEONG ; Tae Yeob KIM ; Oh Sang KWON ; Jeong Han KIM ; Chang Hong LEE ; So Young KWON
The Korean Journal of Hepatology 2011;17(4):307-312
BACKGROUND/AIMS: The incidence of Hepatitis B has significantly declined since the introduction of an HBV vaccination program. The aim of this study was to investigate recent clinical features of acute viral hepatitis B (AVH-B) in Korea. METHODS: A total of 2241 patients with acute viral hepatitis were enrolled and their data were collected from nine medical-centers between January 2006 and December 2009. RESULTS: One hundred nineteen (5.3%) of the 2241 were diagnosed as AVH-B. Among 78 patients with AVH-B whose data were analyzed, 50 were male, and the mean age was 38.6 years. In an initial test, mean AST, ALT and total-bilirubin levels were 1296.2 IU/L, 2109.6 IU/L and 9.3 mg/dl, respectively. Positivity frequencies for HBeAg and anti-HBe were 55.1% and 67.9%, respectively, and the mean HBV DNA level was 5.2 log10 copies/ml. The mean length of hospitalization was 11.6 days. During follow-up, AST, ALT and total bilirubin levels were normalized or near-normalized in all patients without serious complications. Sixty-three of 66 (95.4%) patients showed HBsAg loss and 37 (56.1%) patients showed HBsAg seroconversion. Only 3 patients (4.5%) showed persistent hepatitis B viremia. There was no case of death or liver transplantation. Nine patients (11.3%) had received anti-viral agents and their clinical outcomes were not significantly different from those of patients treated without antiviral agents. CONCLUSIONS: The prevalence of AVH-B among acute hepatitis patients is relatively low in Korea. AVH-B infection can be cured without complications in almost all patients, regardless of antiviral treatment.
Acute Disease
;
Adult
;
Alanine Transaminase/blood
;
Antiviral Agents/therapeutic use
;
Aspartate Aminotransferases/blood
;
Bilirubin/blood
;
DNA, Viral/analysis
;
Female
;
Hepatitis B/*diagnosis/drug therapy/epidemiology
;
Hepatitis B Antibodies/blood
;
Hepatitis B e Antigens/blood/immunology
;
Humans
;
Male
;
Middle Aged
;
Retrospective Studies
3.Clinical features and outcomes of gastric variceal bleeding: retrospective Korean multicenter data.
Moon Young KIM ; Soon Ho UM ; Soon Koo BAIK ; Yeon Seok SEO ; Soo Young PARK ; Jung Il LEE ; Jin Woo LEE ; Gab Jin CHEON ; Joo Hyun SOHN ; Tae Yeob KIM ; Young Suk LIM ; Tae Hyo KIM ; Tae Hee LEE ; Sung Jae PARK ; Seung Ha PARK ; Jin Dong KIM ; Sang Young HAN ; Chang Soo CHOI ; Eun Young CHO ; Dong Joon KIM ; Jae Seok HWANG ; Byoung Kuk JANG ; June Sung LEE ; Sang Gyune KIM ; Young Seok KIM ; So Young KWON ; Won Hyeok CHOE ; Chang Hyeong LEE ; Byung Seok KIM ; Jae Young JANG ; Soung Won JEONG ; Byung Ho KIM ; Jae Jun SHIM ; Yong Kyun CHO ; Moon Soo KOH ; Hyun Woong LEE
Clinical and Molecular Hepatology 2013;19(1):36-44
BACKGROUND/AIMS: While gastric variceal bleeding (GVB) is not as prevalent as esophageal variceal bleeding, it is reportedly more serious, with high failure rates of the initial hemostasis (>30%), and has a worse prognosis than esophageal variceal bleeding. However, there is limited information regarding hemostasis and the prognosis for GVB. The aim of this study was to determine retrospectively the clinical outcomes of GVB in a multicenter study in Korea. METHODS: The data of 1,308 episodes of GVB (males:females=1062:246, age=55.0+/-11.0 years, mean+/-SD) were collected from 24 referral hospital centers in South Korea between March 2003 and December 2008. The rates of initial hemostasis failure, rebleeding, and mortality within 5 days and 6 weeks of the index bleed were evaluated. RESULTS: The initial hemostasis failed in 6.1% of the patients, and this was associated with the Child-Pugh score [odds ratio (OR)=1.619; P<0.001] and the treatment modality: endoscopic variceal ligation, endoscopic variceal obturation, and balloon-occluded retrograde transvenous obliteration vs. endoscopic sclerotherapy, transjugular intrahepatic portosystemic shunt, and balloon tamponade (OR=0.221, P<0.001). Rebleeding developed in 11.5% of the patients, and was significantly associated with Child-Pugh score (OR=1.159, P<0.001) and treatment modality (OR=0.619, P=0.026). The GVB-associated mortality was 10.3%; mortality in these cases was associated with Child-Pugh score (OR=1.795, P<0.001) and the treatment modality for the initial hemostasis (OR=0.467, P=0.001). CONCLUSIONS: The clinical outcome for GVB was better for the present cohort than in previous reports. Initial hemostasis failure, rebleeding, and mortality due to GVB were universally associated with the severity of liver cirrhosis.
Adolescent
;
Adult
;
Aged
;
Aged, 80 and over
;
Asian Continental Ancestry Group
;
Endoscopy
;
Esophageal and Gastric Varices/*diagnosis/mortality/therapy
;
Female
;
*Gastrointestinal Hemorrhage
;
Humans
;
Male
;
Middle Aged
;
Multivariate Analysis
;
Odds Ratio
;
Prognosis
;
Republic of Korea
;
Retrospective Studies
;
Sclerotherapy
;
Severity of Illness Index
;
Treatment Outcome
;
Young Adult